| Assay ID | Title | Year | Journal | Article |
|---|
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID42347 | Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| AID44781 | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| AID44780 | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| AID44783 | Agonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assay | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| AID44782 | Agonistic activity against C-C chemokine receptor type 3 by displacing MCP-4 radioligand, using Eosinophil chemotaxis assay | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| AID44784 | Antagonist activity against C-C chemokine receptor type 3 | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. |
| AID1327073 | Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay | 2016 | Journal of natural products, 08-26, Volume: 79, Issue:8
| Neolignans from the Arils of Myristica fragrans as Potent Antagonists of CC Chemokine Receptor 3. |
| AID44785 | Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand | 2003 | Bioorganic & medicinal chemistry letters, Oct-20, Volume: 13, Issue:20
| Design and synthesis of novel CCR3 antagonists. |
| AID91101 | Ability to block the eotaxin induced intracellular calcium mobilization in primary human eosinophils was determined | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. |
| AID44779 | Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay | 2001 | Bioorganic & medicinal chemistry letters, Jun-04, Volume: 11, Issue:11
| Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |